Flo is a mobile application that provides ovulation and period tracking, fertility calendar, and pregnancy assistance services. The app is used by over 380 million people globally.

Evvy offers an at-home vaginal microbiome test and clinical care options, focusing on vaginal health. It is self-described as the first and only CLIA-certified, mNGS vaginal health test.

Evvy

FemTechLab is an accelerator focused on the global ecosystem of startups, experts, and investors in women’s health and wellness, self-described as a leader in this sector.

FemTechLab

MyClarella offers products designed for postpartum care, including recovery kits, balms, and intimate hygiene items, self-described as innovative.

MyClarella

Flo is on a mission to build a better future for female health. Flo is the largest app in the Health and Fitness category worldwide, with 60 million monthly active users. In the United States, 1 in 6 women (ages 13-45) use Flo, representing 17% of the US population. With over 120+ medical experts, Flo supports women and people who menstruate during their entire reproductive lives and provides curated cycle and ovulation tracking, personalized health insights, expert tips, and a fully closed community to share questions and concerns. Flo prioritizes safety and keeps a sharp focus on being the most trusted digital source for​ ​women's health information. Close to 60% of monthly active users rely on Flo for over a year. Here are a few reasons why millions of women have come to know and love Flo: *Medical Credibility: Flo collaborates with world-class medical research institutions and is the #1 period and cycle tracking app, as recommended by female OB-GYNs.*Flo’s Pass it on Project: This initiative aims to improve health literacy in countries that need it most. Flo has already donated over 11 million free Flo Premium subscriptions across 66 countries. Our goal is to give up to 1 billion women in need access to Flo Premium for free on Android devices.*Privacy Pioneer: Flo's award-winning Anonymous Mode feature has been recognized as one of Fast Company’s 2023 World Changing Ideas, as well as Time’s Best Inventions of 2023. We are the first and only period tracking app with dual privacy and security certifications (ISO 27701 & ISO 27001).*Market Leadership: Flo is the #1 women's health app worldwide with 60 million monthly active users. It is the #1 Health and Fitness app in the US with 10 million monthly active users. For more information, please visit https://flo.health 

Metric
Company Name	Flo	Evvy	FemTechLab	MyClarella
Symbol
MSH ID	HEALTH:FLO	COM:EVVY	COM:FEMTECHLAB	COM:MYCLARELLA
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services	Consumer Goods
Industry	Digital Health	Medical Diagnostics	Health & Wellness	Healthcare & Health Services
Country	US	US	UK	DE
Stage
Employee Count	604
Website	flo.health	evvy.com	femtechlab.com	myclarella.com
LinkedIn	flohealth
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	6.56M
Web Traffic Growth	-0.15
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HEALTH:FLO

Flo

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue